SCV-based peanut allergy vaccine (aVaxziPen/Sementis)

N/A

Report date: 2025/01/26 17:03:28

Base Information

Drug NameSCV-based peanut allergy vaccine (aVaxziPen/Sementis)
Drug Alias NameSementis Copenhagen Vector-based peanut allergy vaccine (aVaxziPen/Sementis)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPeanut Hypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesaVaxziPen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSementis LtdaVaxziPen Ltd
Inactive CompaniesN/A
Active IndicationsPeanut Hypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A